Cleared Traditional

K130097 - MEDMATE TRANSFER ADAPTER AM5500 & AM5500-NS

K130097 is an FDA 510(k) clearance for MEDMATE TRANSFER ADAPTER AM5500 & AM5500-NS, manufactured by American Medical Manufacturing, Inc./ Advanced Med. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 553-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
553d
Days
Class 2
Risk

K130097 is an FDA 510(k) clearance for the MEDMATE TRANSFER ADAPTER AM5500 & AM5500-NS. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by American Medical Manufacturing, Inc./ Advanced Med (Northridge, US). The FDA issued a Cleared decision on July 22, 2014 after a review of 553 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all American Medical Manufacturing, Inc./ Advanced Med devices

FDA 510(k) Submission Details - K130097

510(k) Number K130097 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 2013
Decision Date July 22, 2014
Days to Decision 553 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
424d slower than avg
Panel avg: 129d · This submission: 553d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 310
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K130097.
BD Eclipse Hypodermic Needle
K161170 · Becton, Dickinson and Company · May 2016
K-Pack II Needle - 29G x 5/16 Thin Wall
K151398 · Terumo Europe N.V. · Jun 2015
K-Pack II Needle-21G x 2
K150263 · Terumo Europe N.V. · Apr 2015
EZ-IO INTRAOSSEOUS INFUSION SYSTEM
K132583 · Vidacare Corporation · Feb 2014
K-PACK II NEEDLE - 27G X 3/4 THIN WALL
K132233 · Terumo Europe N.V. · Sep 2013
STERICAN CANNULA
K131842 · B.Braun Medical, Inc. · Aug 2013